MDx/CDx Focus: NeoGenomics Launches NeoType for CLL; Results for Interleukin's PST Test; and More
August 22, 2012
MDx/CDx Focus: NeoGenomics Launches NeoType for CLL; Results for Interleukin's PST Test; and More
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- With Large Study, Interleukin Hopes to Drive Adoption, Reimbursement of Dx for Personalized Dental Care
April 11, 2012 / Pharmacogenomics Reporter - U of Michigan, Interleukin Collaborate on Clinical Study to Reduce Dentist Visits with the Help of Gene Test
March 28, 2012 / Pharmacogenomics Reporter - Interleukin Genetics Raises $12M in Private Placement
May 20, 2013 / GenomeWeb Daily News - Cancer Test Firm NeoGenomics Reports Q1 Revenues up 3 Percent
April 25, 2013 / GenomeWeb Daily News - Interleukin Genetics' Q4 Revenues Fall 41 Percent; Firm Cautions on Financial Resources
March 29, 2013 / GenomeWeb Daily News